Institute for Translational Research

Organization profile

Organization profile

The Institute for Translational Sciences (ITS) aims to train a new generation of clinical and translational researchers, engage stakeholders and communities in research, address barriers to clinical and translational research, and advance translational research through team-based approaches. The ITS, established in 2007, is the academic home of UTMB’s Clinical Translational Sciences Award (CTSA), funded by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS). CTSA institutions work together to speed the translation of research discoveries into improved health. 

David Urban, Director

Fingerprint Dive into the research topics where Institute for Translational Research is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Respiratory Syncytial Viruses Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Respiratory Syncytial Virus Infections Medicine & Life Sciences
Epithelial Cells Medicine & Life Sciences
Cyclin-Dependent Kinase 9 Medicine & Life Sciences
Proteins Medicine & Life Sciences
Genes Medicine & Life Sciences
Proteomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

Research Output 1994 2019

17 Citations (Scopus)

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

Wilder-Smith, A., Hombach, J., Ferguson, N., Selgelid, M., O'Brien, K., Vannice, K., Barrett, A., Ferdinand, E., Flasche, S., Guzman, M., Novaes, H. M., Ng, L. C., Smith, P. G., Tharmaphornpilas, P., Yoon, I. K., Cravioto, A., Farrar, J. & Nolan, T. M., Jan 1 2019, In : The Lancet Infectious Diseases. 19, 1, p. e31-e38

Research output: Contribution to journalReview article

Dengue Vaccines
Immunization
Vaccination
Vaccines
Dengue
Essential Amino Acids
Insulin Resistance
Randomized Controlled Trials
Exercise
Placebos

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination

Wilder-Smith, A., Barrett, A., Vannice, K. & Hombach, J., Jul 16 2019, In : Annals of internal medicine. 171, 2, p. 145-146 2 p.

Research output: Contribution to journalArticle

Prizes

Scholar, Translational Research Scholar Program

Tomoko Makishima (Recipient), Aug 2010

Prize: Other distinction